- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
David Hung will become Axovant's CEO after completing the $14 billion sale of Medivation to Pfizer.
ChemoCentryx, Jazz Pharmaceuticals, Ionis Pharmaceuticals and Zogenix were among the biotech stock movers in premarket trading Friday.
Jim Cramer looks for domestic stocks he thinks will benefit from lower taxes and deregulation in the Trump era.